12399456https://www.upal.com.my/zh/feeds/jobFeedKwongwahArray ( [0] => HTTP/1.1 200 OK [1] => Date: Sat, 10 Jan 2026 21:57:19 GMT [2] => Content-Type: text/xml; charset=utf-8 [3] => Connection: close [4] => Cache-Control: no-cache, private [5] => Cache-Control: no-cache, no-store, must-revalidate [6] => Set-Cookie: UpalLiveSession=eyJpdiI6IlJRZU1WWXBFSFhWbWF6aEFxSzI1RHc9PSIsInZhbHVlIjoiRUFEYU5vNGp3NUk5TzRLU29CaUhpWkNIOXU2VW9neHhKQ3ZIWjlrcFBWXC9QUEVyMVJDWVBOaWtPUHJyeXk3Vyt0NEJJemk0Rm9US212R3U2U2U2clZRPT0iLCJtYWMiOiI0OWY3OWE5ZDM0YmMzNmEzMzY5MmZjNjE0NTJjODgyYTU1ZDNjZDY5MjYyYjAyODY3ZDIxY2ViNWIxNDdlNmVmIn0%3D; expires=Tue, 09-Jan-2029 21:57:19 GMT; Max-Age=94608000; path=/; HttpOnly [7] => x-frame-options: SAMEORIGIN [8] => x-content-type-options: nosniff [9] => x-xss-protection: 1; mode=block [10] => referrer-policy: strict-origin-when-cross-origin [11] => permissions-policy: geolocation=(), microphone=(), camera=() [12] => content-security-policy: default-src * 'unsafe-inline' 'unsafe-eval' data: blob:; script-src * 'unsafe-inline' 'unsafe-eval' data: blob:; style-src * 'unsafe-inline' data:; img-src * data: blob:; font-src * data:; connect-src *; frame-src *; object-src *; media-src *; child-src *; [13] => Server: cloudflare [14] => x-robots-tag: noindex, nofollow, nosnippet, noarchive [15] => strict-transport-security: max-age=31536000; includeSubDomains; preload [16] => expires: Sun, 11 Jan 2026 21:57:19 GMT [17] => vary: Accept-Encoding [18] => Report-To: {"group":"cf-nel","max_age":604800,"endpoints":[{"url":"https://a.nel.cloudflare.com/report/v4?s=QkM6AEPjXSaTzFEPYU%2FaSAPiUF%2FE5FMM5EOVel03s2C8gFP%2Bc%2BsRsn5xgvlPVlI%2Ftyn5WUsG%2B6XM5KvdT17mANSjEIxalnougQkhrpp9Ug%3D%3D"}]} [19] => cf-cache-status: DYNAMIC [20] => Nel: {"report_to":"cf-nel","success_fraction":0.0,"max_age":604800} [21] => Speculation-Rules: "/cdn-cgi/speculation" [22] => Server-Timing: cfCacheStatus;desc="DYNAMIC" [23] => Server-Timing: cfEdge;dur=6,cfOrigin;dur=813 [24] => CF-RAY: 9bbf6de8ad580fc8-LAX [25] => alt-svc: h3=":443"; ma=86400 ) 789

针对新加坡科学局宣布召回3种含有超标致癌物质的药物二甲双胍（metformin），我国卫生部周四发文告强调，我国并没批准发售这3种药物。

这3种药物包括Glucient XR Tablet 500mg、Meijumet Prolonged Release Tablet 750mg，以及Meijumet Prolonged Release Tablet 1000mg；有关药物是控制血糖的药物。

卫生总监拿督诺希山周四在文告中指出，卫生部对国家药品监管局（NPRA）注册的药物进行审查后发现，美国药物管制局共检验101项药物含有二甲双胍成份，然而只有获得注册的药物才获准在我国发售。

文告指，NDMA是亚硝胺基的杂质之一，通常含量较低。“根据国际癌症研究机构（IARC）显示，长期服用NDMA将增加患癌风险。”

“二甲双胍是一种治疗糖尿病以控制血糖的药物，平时可从医生或药剂师处获取。”

无论如何，国家药品监管局将继续监视市面上的药物，确保药物的质量、安全和有效性，并随时提醒民众。

---

// // // //